See if 5-HTP helps with ADHD traits and eye movements
Official title: The Effect of 5-hydroxytryptophan on Microsaccades and Distractibility in Individual With High Levels of ADHD Traits: a Randomised, Double-blind Trial
Run by University of Sheffield · NCT07777328 · Data updated 2026-11-12
This study tests whether taking 5-HTP can reduce distractibility in adults with ADHD by comparing 5-HTP to a placebo during brain and eye-movement tasks.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 150 (estimated) |
| Sponsor | University of Sheffield Academic / other |
| Locations | 1 site (Sheffield, South Yorkshire) |
| Status | Recruiting |
| Started | November 25, 2025 |
| Main results expected | February 2027 |
| Study ends | June 2027 |
| Registry record updated | August 20, 2026 |
| Trial ID | NCT07777328 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults 18–65 with ADHD traits who have normal or corrected vision and are not taking stimulants or serotonergic medications.
✕Probably not a fit
Participants with certain medications, lifestyle factors, or conditions may not experience benefit and may be excluded.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
Adults aged 18–65 with ADHD-related traits will complete screening questionnaires and, if eligible, a in-person session at the University of Sheffield. Participants will receive either 200 mg or 300 mg of 5-HTP or a placebo, then perform cognitive tasks while eye movements are recorded, followed by a 90-minute waiting period and a second task run. The aim is to explore whether 5-HTP can influence attention and eye-movement patterns that are linked to distractibility. This is an early, pilot-type investigation using a short-term administration of a nutritional supplement. The study is exploratory and focused on initial signals of efficacy and safety in this context.
Why it matters
Potential benefit: If successful, 5-HTP could be studied further as a potential supplement to help manage distractibility in ADHD traits.
How similar studies have gone: Prior animal work suggested increased attention with 5-HTP, but human data in ADHD are limited and this study is among the initial human tests.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * 18-65 years of age * Normal or corrected to normal vision with contact lenses. * Score of \<9 or \>14 on the ASRS v5 (assessed in pre screen questionnaire) Exclusion Criteria: * Current use of psychostimulant medication or medication for the treatment of ADHD * Current use of medications known to impact the serotonergic system (e.g., SSRIs). * Smoking or vaping * Pregnancy * Breast feeding * Lactose intolerance * Veganism * Dyslexia
Where it's running
-
University of Sheffield
Sheffield, South Yorkshire, United Kingdom Recruiting
Study contacts
- Study coordinator: Eleanor F Jackson
- Email: efjackson1@sheffield.ac.uk
- Phone: +447908873415
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Is a steam mask better than warm compresses for kids with a chalazion?
A steam mask is tested to see if it helps pediatric chalazia more than traditional warm compresses.
-
Telehealth in MND: TiM online platform for people with MND
This project lets people with MND in the UK use an online telehealth platform to learn about and sign up for MND studies and share health information from home.
-
Low sex‑hormone levels in genetic neurodevelopmental conditions
This project will test whether people with certain genetic neurodevelopmental conditions have low sex hormones (hypogonadism) and how common it is.
-
Comparing CAT-guided self-help and CBT-guided self-help for people returning to NHS talking therapy
This project will try CAT-guided self-help and compare it with CBT-guided self-help for people with anxiety or low mood who are returning to NHS Talking Therapies.
-
Identifying pathogens in febrile patients using gene expression
This study is trying to find out if looking at gene responses in feverish patients can help doctors quickly tell if they have enteric fever or another infection, especially in places with limited resources.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.